Last update 01 Nov 2024

γ-globin x HDAC2 x HDAC1

Basic Info

Related Targets
γ-globinHDAC2HDAC1

Related

1
Drugs associated with γ-globin x HDAC2 x HDAC1
ACY-1497
Target
HDAC1 x HDAC2 x γ-globin
Mechanism
HDAC1 inhibitors [+2]
Active Org.-
Originator Org.
Regenacy Pharmaceuticals LLCRegenacy Pharmaceuticals LLCStartup
Active Indication-
Inactive Indication
Anemia, Sickle Cell [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with γ-globin x HDAC2 x HDAC1
Login to view more data
100 Translational Medicine associated with γ-globin x HDAC2 x HDAC1
Login to view more data
0 Patents (Medical) associated with γ-globin x HDAC2 x HDAC1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free